Multi-Component Technology Intervention for Minority Emerging Adults With Asthma
1 other identifier
interventional
48
0 countries
N/A
Brief Summary
This pilot study's main goal is to develop and preliminarily test a technology-based intervention to improve asthma medication adherence in urban African American emerging adults (ages 18-29). It is hypothesized that youth randomized to MCTI for adherence will show improvements in motivation to adhere to asthma medications and self-reported adherence compared to the comparison condition at 1- and 3- month follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable asthma
Started Dec 2011
Longer than P75 for not_applicable asthma
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 17, 2012
CompletedFirst Posted
Study publicly available on registry
October 25, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedNovember 1, 2016
October 1, 2016
3.8 years
October 17, 2012
October 31, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in medication adherence
Self-reported adherence to asthma controller medication(s) through questionnaire report and, at baseline and 3 months, 7 days of momentary (real time) sampling of adherence behavior via SMS text messaging.
baseline, 1 month, 3 month
Change in motivation for medication adherence
Self-report of motivation to take asthma controller medications as prescribed.
baseline, 1 month, 3 month
Secondary Outcomes (7)
Change in asthma knowledge
baseline, 1 month, 3 month
Change in asthma medication confidence
Baseline, 1 month, 3 month
Change in asthma medication importance
baseline, 1 month, 3 month
Change in asthma control
baseline, 1 month, 3 month
Change in barriers to taking medication
baseline, 1 month, 3 months
- +2 more secondary outcomes
Study Arms (2)
Multi-component, technology based intervention
EXPERIMENTAL2 tailored, computer-delivered motivational interviewing sessions targeting adherence to asthma control medications + tailored text messaged reminders to take medications between sessions.
Asthma education active control
ACTIVE COMPARATORControl condition consists of active control matched to intervention for delivery-method and time-- 2 sessions of computer-delivered asthma education + daily text messaged facts about asthma.
Interventions
Motivational sessions were adapted from work done with young adults with HIV (MESA).
Eligibility Criteria
You may qualify if:
- African American Live in the Detroit Area, approximately 30 miles from the Hutzel Building Ages 18-29
- Have moderate to severe persistent asthma. Persistent asthma is defined according to the 2007 NHLBI guidelines. The level of symptoms, as defined by any of the following in the last 4 weeks:
- Use of any asthma medication more than 2 times a week Daytime asthma symptoms such as wheezing, tightness of chest, problems coughing more than 2 times a week, or waking up at night because of asthma more than 2 times a month
- Participant is prescribed a daily asthma controller medication, even if they do not take it.
- Participant must report poor adherence to daily controller medications during eligibility screening (brief interview).
- Poor adherence is defined as not taking medications "as prescribed" less than 4 days per week in any of the 4 weeks prior to enrollment OR as a proxy of poor adherence as self-report of \<80% medication adherence in the past 30 days, self-report of emergency room visit/hospitalization for asthma in the past 6 months, or a poor score on the Asthma Control Test.
You may not qualify if:
- Individuals with other chronic health conditions requiring ongoing medical intervention ( e.g., HIV, Type II Diabetes) will be excluded.
- These chronic diseases include: Glaucoma, bi-polarism, segmented glomerular nephritis, cystic fibrosis, spondyloarthropathy, congenital heart disease, sickle cell
- No pregnant women will be included in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Kolmodin MacDonell K, Naar S, Gibson-Scipio W, Lam P, Secord E. The Detroit Young Adult Asthma Project: Pilot of a Technology-Based Medication Adherence Intervention for African-American Emerging Adults. J Adolesc Health. 2016 Oct;59(4):465-71. doi: 10.1016/j.jadohealth.2016.05.016. Epub 2016 Jul 27.
PMID: 27475032RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistante Professor
Study Record Dates
First Submitted
October 17, 2012
First Posted
October 25, 2012
Study Start
December 1, 2011
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
November 1, 2016
Record last verified: 2016-10